- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
C
CLNN
Clene
10.51
2.50+31.21%After Hours: 11.28 +0.77 +7.33%16:38 10/03 EDT
OPEN/PREV CLOSE8.01/8.01
TODAY RANGE7.79-10.58
VOL510.78K
MARKET CAP105.84M
52 WEEK RANGE2.280-10.58
AVG VOL (3M)95.30K
% TURNOVER5.07%
TURNOVER--
P/E (TTM)-2.8465
% RANGE34.79%
EPS(TTM)-3.6923
P/E(FORWARD)-4.7773
P/B-11.6313
BVPS-0.9036
DIVIDEND--
P/S248.46
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP73.20M
SHARES OUTSTANDING10.07M
NEXT EARNINGS11/11-11/17
FREE FLOAT6.96M
LOT SIZE1
EX-DATE07/11/2024
News
Press Releases
Financial Reports
Profile
TipRanks·09/25 17:35
Buy Rating for Clene Driven by Promising CNM-Au8 Developments and FDA Support
TipRanks·09/25 12:29
Clene Unveils Promising Clinical Data at ECTRIMS 2025
Dow Jones·09/25 12:27
Clene Price Target Maintained With a $23.00/Share by D. Boral Capital
Dow Jones·09/25 12:27
Clene Is Maintained at Buy by D. Boral Capital
TipRanks·09/25 12:10
Clene announces presentation of combined REPAIR-MS results
Dow Jones·09/10 12:32
Clene Is Maintained at Buy by Benchmark
Dow Jones·09/10 12:32
Clene Price Target Cut to $31.00/Share From $33.00 by Benchmark
Benzinga·09/10 12:21
Benchmark Maintains Buy on Clene, Lowers Price Target to $31
TipRanks·09/10 12:00
Clene price target lowered to $31 from $33 at Benchmark
Reuters·09/10 11:32
CLENE INC <CLNN.O>: BENCHMARK CUTS TARGET PRICE TO $31 FROM $33
TipRanks·09/05 20:49
Clene Expands Equity Distribution to Raise Capital
Seeking Alpha·09/05 20:37
Clene files to sell 491,496 shares of common stock by selling shareholders
Benzinga·09/05 20:28
Clene Files Prospectus Supplement For $6.28M Shares
Same Industry
Name/Symbol
Change%
Price